
The hefty funding will support a U.S. and China-based startup that’s amassed a pipeline of nearly 20 drugs and formed two lucrative partnerships with Sanofi.

The hefty funding will support a U.S. and China-based startup that’s amassed a pipeline of nearly 20 drugs and formed two lucrative partnerships with Sanofi.
Autologous therapies need data-driven manufacturing and supply chain mastery. Integrated CDMOs combine both functions to…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
The drug, being developed for a rare genetic disorder and currently under review in the U.S., is seen by some…
Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in…
Backed by Ananda Impact Ventures and ReGen Ventures, along with Carbon13, Climate Capital, Better Ventures, CDTM Ventures, and several angel…
The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses…
Sign in to your account